Invest now
Granules India share price
Balanced risk
You have to be logged in to add this to Watchlist.- ₹870.00(3.79%)August 7, 2026 15:29:49 PM IST
- NSE
- BSE
- Vol : 1.17 M (NSE + BSE)Last 20 day avg : 1.03 M
Granules India is trading 3.79% upper at Rs 870.00 as compared to its last closing price. Granules India has been trading in the price range of 882.05 & 835.50. Granules India has given 40.13% in this year & 0.56% in the last 5 days. Granules India has TTM P/E ratio 30.05 as compared to the sector P/E of 30.34.There are 8 analysts who have initiated coverage on Granules India. There are 2 analysts who have given it a strong buy rating & 5 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 179.96 Crores in its last quarter.Listed peers of Granules India include Sun Pharmaceutical Industries (0.26%), Divi's Laboratories (-0.52%), Torrent Pharmaceuticals (-0.26%).The Mutual Fund holding in Granules India was at 3.45% in 30 Jun 2026. The MF holding has increased from the last quarter. The FII holding in Granules India was at 17.50% in 30 Jun 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 08 Aug 2026, 01:19 AM IST
- BetaMedium volatility0.86Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.30The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.21Annual dividends as a percentage of the stock price.
- P/BHigher than historical values4.09The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values31.17Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates overvaluation6.02The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Granules India News
Granules India Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,949.00 | 0.26 | 4,67,619.37 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 8,248.50 | -0.52 | 2,18,971.76 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,952.00 | -0.26 | 1,88,351.43 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,472.00 | -0.20 | 1,18,914.83 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,115.20 | 0.81 | 1,11,241.63 | 21.19 | 4.24 | 0.09 | 14.22 |
Mutual Fund Ownership
View allGranules India Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-07-21 | Quarterly Results |
| 2026-04-29 | Audited Results & Final Dividend |
| 2026-01-23 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
About the company Granules India
- IndustryBiotechnology & Drugs
- ISININE101D01020
- BSE Code532482
- NSE CodeGRANULES
Granules India Limited is an India-based pharmaceutical manufacturing company. The Company operates through its pharmaceutical products segment. Its geographical segments include within India and outside India. The Company has a presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). It produces and supplies Paracetamol, Metformin, Guaifenesin, and Methocarbamol APIs. It has over 10 manufacturing facilities, approximately eight of which are located in India and two in the United States. The Company sells its products in global markets, including the United States of America, Canada, Latin America, Europe, Asia Pacific, and India. Its subsidiaries include Granules USA Inc and Granules Europe Limited. It also owns Senn Chemicals AG, a contract development and manufacturing organization (CDMO) specializing in peptide development and manufacturing.
Granules India Share Price FAQs
Granules India is trading at 870.00 as on Fri Aug 07 2026 09:59:49. This is 3.79% upper as compared to its previous closing price of 838.20.
The market capitalization of Granules India is 21486.56 Cr as on Fri Aug 07 2026 09:59:49.
The average broker rating on Granules India is Buy. The breakup of analyst rating is given below -
- 2 analysts have given a strong buy rating
- 5 analysts have given a buy rating
- 1 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Granules India is 910.00 whereas the 52 wk low is 433.00
Granules India can be analyzed on the following key metrics -
- TTM P/E: 30.05
- Sector P/E: 30.34
- Dividend Yield: 0.21%
- D/E ratio: -
Granules India reported a net profit of 595.02 Cr in 2026.
The Mutual Fund Shareholding was 3.45% at the end of 30 Jun 2026.
Quick Links
EQUITY QUICK LINKS
Granules India QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.